首页 > 最新文献

International Clinical Neuroscience Journal最新文献

英文 中文
Neurological Manifestation of COVID-19: A Literature Review COVID-19的神经学表现:文献综述
Pub Date : 2020-09-28 DOI: 10.34172/ICNJ.2020.20
Arash Azhideh, Iman Menbari-Oskouie, Maryam Yousefi-Asl
In December 2019, the coronavirus ((COVID-19) outbreak related to severe acute respiratory syndrome (SARS-CoV2) originated in China and expanded exponentially as a public health pandemic to over 200 countries. Over 8 million validated cases and approximately 800 000 deaths. The main type is cardiac and respiratory but neurological symptoms are further mentioned as case series and case records in the research. The most frequent manifestations have been reported to include dizziness and headache followed by delirium and encephalopathy. Gillian barre syndrome, acute transversal myelitis, cerebrovascular accident, and encephalitis are among the complications noted. The most prominent occurrence at the periphery was hyposmia. This is also known that neurological demonstrations will also lead to regular features such as cough and fever, which evolve in these cases later on normal manifestations. For the timely diagnosis and separation of cases, therefore, a great suspicion guide is needed to arrest spread in neurology departments. This research provides a narrative study of COVID-19’s neurological symptoms and complexities. Our goal is to inform the neurologists and clinicians who work amidst potential COVID-19 patients regarding potential neurological symptoms, and likely neurological problems arising from the aforementioned new virus.
2019年12月,与严重急性呼吸综合征(SARS-CoV2)相关的冠状病毒(新冠肺炎)疫情起源于中国,并作为一种公共卫生大流行呈指数级扩大到200多个国家。超过800万例确诊病例,约80万人死亡。主要类型是心脏和呼吸系统症状,但神经系统症状在研究中作为病例系列和病例记录被进一步提及。据报道,最常见的表现包括头晕和头痛,其次是谵妄和脑病。Gillian-barre综合征、急性横贯性脊髓炎、脑血管意外和脑炎是注意到的并发症。最突出的发生在周边是尿道下裂。众所周知,神经系统的表现也会导致咳嗽和发烧等规律性特征,这些特征在这些情况下会在以后的正常表现中演变。因此,为了及时诊断和分离病例,需要一个很好的怀疑指南来阻止神经科的传播。这项研究对新冠肺炎的神经系统症状和复杂性进行了叙述性研究。我们的目标是向在潜在新冠肺炎患者中工作的神经科医生和临床医生通报上述新病毒引起的潜在神经系统症状和可能的神经系统问题。
{"title":"Neurological Manifestation of COVID-19: A Literature Review","authors":"Arash Azhideh, Iman Menbari-Oskouie, Maryam Yousefi-Asl","doi":"10.34172/ICNJ.2020.20","DOIUrl":"https://doi.org/10.34172/ICNJ.2020.20","url":null,"abstract":"In December 2019, the coronavirus ((COVID-19) outbreak related to severe acute respiratory syndrome (SARS-CoV2) originated in China and expanded exponentially as a public health pandemic to over 200 countries. Over 8 million validated cases and approximately 800 000 deaths. The main type is cardiac and respiratory but neurological symptoms are further mentioned as case series and case records in the research. The most frequent manifestations have been reported to include dizziness and headache followed by delirium and encephalopathy. Gillian barre syndrome, acute transversal myelitis, cerebrovascular accident, and encephalitis are among the complications noted. The most prominent occurrence at the periphery was hyposmia. This is also known that neurological demonstrations will also lead to regular features such as cough and fever, which evolve in these cases later on normal manifestations. For the timely diagnosis and separation of cases, therefore, a great suspicion guide is needed to arrest spread in neurology departments. This research provides a narrative study of COVID-19’s neurological symptoms and complexities. Our goal is to inform the neurologists and clinicians who work amidst potential COVID-19 patients regarding potential neurological symptoms, and likely neurological problems arising from the aforementioned new virus.","PeriodicalId":33222,"journal":{"name":"International Clinical Neuroscience Journal","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42621312","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
Leaving Against Medical Advice Among Patients With Brain Tumours in the Middle East: Khoula Hospital Experience 中东脑肿瘤患者违背医嘱离开:Khoula医院的经验
Pub Date : 2020-09-28 DOI: 10.34172/ICNJ.2020.22
T. Al-Saadi, A. Alsharqi, Jawahir ALSharqi, Khadija ALBulushi, Asma A. Alrasbi, Maather Al-Farsi, Shamsa Al-Ghafri, S. Al-Abri, H. Al-Saadi
Background: Leaving against medical advice (LAMA) can be defined broadly as a patient’s insistence upon leaving the hospital against the treating team has expressed advice, which is both a challenge and concern for physicians, as these patients lost to follow-up, and their outcomes remain unknown. There is no previous study conducted to find the prevalence and causes of LAMA in brain tumors patients in the Middle East to the best of our knowledge.Methods: Patients studied in this research are those who were diagnosed with any type of brain tumors and were admitted to the Neurosurgical Department in Khoula Hospital (KH) but signed LAMA in the two years between January 2017 to December 2018 by going through the electronic medical records. Data obtained from the health information system includes socioeconomic characteristics, health status-related data, diagnosis-related data, and the reasons for LAMA.Results: A total number of 302 patients with brain tumors included in this study. Twenty-eight patients (9.2%) signed LAMA with a majority of those who signed LAMA were in the young adult’s group (3-39 years) and represented 18 (64%). Eight patients (28.57%) among the LAMA group and 43 patients (15.69%) in the non-LAMA group have tumors in the frontal lobe, which has found to be the most familiar location (29%). There was a significant relationship between the reason for LAMA and gender (P = 0.020).Conclusion: Younger patients, male, Omani, newly diagnosed tumors, and tumors in the frontal lobe were all risk factors for LAMA. Education and awareness about LAMA recommended in order to avoid readmission and loss of follow up.
背景:逆医嘱离开(LAMA)可以广义地定义为患者不顾治疗团队的建议而坚持离开医院,这对医生来说既是挑战也是担忧,因为这些患者失去了随访机会,其结果仍然未知。据我们所知,中东地区脑肿瘤患者的LAMA患病率和发病原因尚无相关研究。方法:本研究研究的患者是2017年1月至2018年12月通过电子病历签署LAMA的两年内在Khoula医院(KH)神经外科确诊为任何类型脑肿瘤的患者。从卫生信息系统获得的数据包括社会经济特征、健康状况相关数据、诊断相关数据以及LAMA的原因。结果:本研究共纳入302例脑肿瘤患者。28例患者(9.2%)签署了LAMA,其中大多数签署了LAMA的患者为青壮年组(3-39岁),占18例(64%)。LAMA组有8例(28.57%)患者和非LAMA组有43例(15.69%)患者的肿瘤位于额叶,额叶已被发现是最熟悉的位置(29%)。造成LAMA的原因与性别有显著相关(P = 0.020)。结论:年轻、男性、阿曼人、新诊断肿瘤、额叶肿瘤均为LAMA的危险因素。建议进行有关LAMA的教育和认识,以避免再入院和失去随访。
{"title":"Leaving Against Medical Advice Among Patients With Brain Tumours in the Middle East: Khoula Hospital Experience","authors":"T. Al-Saadi, A. Alsharqi, Jawahir ALSharqi, Khadija ALBulushi, Asma A. Alrasbi, Maather Al-Farsi, Shamsa Al-Ghafri, S. Al-Abri, H. Al-Saadi","doi":"10.34172/ICNJ.2020.22","DOIUrl":"https://doi.org/10.34172/ICNJ.2020.22","url":null,"abstract":"Background: Leaving against medical advice (LAMA) can be defined broadly as a patient’s insistence upon leaving the hospital against the treating team has expressed advice, which is both a challenge and concern for physicians, as these patients lost to follow-up, and their outcomes remain unknown. There is no previous study conducted to find the prevalence and causes of LAMA in brain tumors patients in the Middle East to the best of our knowledge.Methods: Patients studied in this research are those who were diagnosed with any type of brain tumors and were admitted to the Neurosurgical Department in Khoula Hospital (KH) but signed LAMA in the two years between January 2017 to December 2018 by going through the electronic medical records. Data obtained from the health information system includes socioeconomic characteristics, health status-related data, diagnosis-related data, and the reasons for LAMA.Results: A total number of 302 patients with brain tumors included in this study. Twenty-eight patients (9.2%) signed LAMA with a majority of those who signed LAMA were in the young adult’s group (3-39 years) and represented 18 (64%). Eight patients (28.57%) among the LAMA group and 43 patients (15.69%) in the non-LAMA group have tumors in the frontal lobe, which has found to be the most familiar location (29%). There was a significant relationship between the reason for LAMA and gender (P = 0.020).Conclusion: Younger patients, male, Omani, newly diagnosed tumors, and tumors in the frontal lobe were all risk factors for LAMA. Education and awareness about LAMA recommended in order to avoid readmission and loss of follow up.","PeriodicalId":33222,"journal":{"name":"International Clinical Neuroscience Journal","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43453315","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
Drug Interactions in Iranian Veterans With Chronic Spinal Cord Injury - A Descriptive Study 伊朗退伍军人慢性脊髓损伤的药物相互作用-一项描述性研究
Pub Date : 2020-09-28 DOI: 10.34172/ICNJ.2020.25
Ashkan Divanbeigi, A. Seddighi, Sepideh Amiri, S. Jamshidi, Hesam Rahimi Baghdashti, Afsoon Seddighi
Background: Veterans with chronic spinal cord injury usually have various comorbidities. They are, therefore, visited by different doctors and use different medications. It is necessary to monitor the health of these veterans. One of the important issues in this regard is the attention to drug interactions. The purpose of this study was to investigate the drugs used and their interactions.Methods: This descriptive study of the cross-sectional studies was carried out retrospectively in 2015 under the Shefa Neuroscience Research Center’s supervision, examining the medical records of veterans with spinal cord injury participating in the health screening program at Khatam Alanbiya hospital in Tehran. Demographic data, comorbidities, used drugs, and the level of involvement collected. According to the FDA, drug interactions among the drugs used for each patient has evaluated and classified into three severe, moderate, and weak groups. SPSS v. 21 analyzed data.Results: The study population consisted of 404 men, ranging in age from 41 to 74, with a mean of 51.6 ± 6.4 years. One hundred forty-two of them (35.1%) had a complete injury, and 262 veterans (64.8%) had an incomplete injury. Only 17 veterans (4.2%) had no drug interactions. The number of drug interactions varied from 1 to 38, with an average of 5.9 ± 12.8 interactions per patient. The total number of interactions was 2856, of which 32.5% were weak, 55.3% moderate, and 12.2% severe, with a 95% confidence interval. Among the severe drug interactions in the study, the highest number belonged to the antidepressant drugs.Conclusion: This study highlights the necessity of developing a strategy for investigating and preventing drug interactions in veterans with chronic spinal cord injury. It has recommended that physicians pay more attention to other medications used by the patient and prescribe as little as possible of the drug and the drug with the least number of interactions.
背景:退伍军人慢性脊髓损伤通常有多种合并症。因此,他们被不同的医生拜访,使用不同的药物。有必要监测这些退伍军人的健康状况。这方面的一个重要问题是对药物相互作用的关注。本研究的目的是调查所使用的药物及其相互作用。方法:在Shefa神经科学研究中心的指导下,回顾性分析2015年在德黑兰Khatam Alanbiya医院参加健康筛查项目的脊髓损伤退伍军人的医疗记录,进行横断面研究的描述性研究。收集人口统计数据、合并症、使用药物和参与程度。根据FDA的规定,每个患者使用的药物之间的相互作用已经被评估并分为三个严重、中度和弱组。SPSS v. 21分析数据。结果:研究人群包括404名男性,年龄41 ~ 74岁,平均年龄51.6±6.4岁。其中完全性损伤142人(35.1%),完全性损伤262人(64.8%)。只有17名退伍军人(4.2%)没有药物相互作用。药物相互作用次数为1 ~ 38次,平均每位患者发生5.9±12.8次相互作用。总交互次数为2856次,其中32.5%为弱交互,55.3%为中度交互,12.2%为重度交互,可信区间为95%。在研究中严重的药物相互作用中,抗抑郁药物的数量最多。结论:本研究强调了制定研究和预防慢性脊髓损伤退伍军人药物相互作用策略的必要性。它建议医生更多地关注患者使用的其他药物,并尽可能少地开这种药物和相互作用最少的药物。
{"title":"Drug Interactions in Iranian Veterans With Chronic Spinal Cord Injury - A Descriptive Study","authors":"Ashkan Divanbeigi, A. Seddighi, Sepideh Amiri, S. Jamshidi, Hesam Rahimi Baghdashti, Afsoon Seddighi","doi":"10.34172/ICNJ.2020.25","DOIUrl":"https://doi.org/10.34172/ICNJ.2020.25","url":null,"abstract":"Background: Veterans with chronic spinal cord injury usually have various comorbidities. They are, therefore, visited by different doctors and use different medications. It is necessary to monitor the health of these veterans. One of the important issues in this regard is the attention to drug interactions. The purpose of this study was to investigate the drugs used and their interactions.Methods: This descriptive study of the cross-sectional studies was carried out retrospectively in 2015 under the Shefa Neuroscience Research Center’s supervision, examining the medical records of veterans with spinal cord injury participating in the health screening program at Khatam Alanbiya hospital in Tehran. Demographic data, comorbidities, used drugs, and the level of involvement collected. According to the FDA, drug interactions among the drugs used for each patient has evaluated and classified into three severe, moderate, and weak groups. SPSS v. 21 analyzed data.Results: The study population consisted of 404 men, ranging in age from 41 to 74, with a mean of 51.6 ± 6.4 years. One hundred forty-two of them (35.1%) had a complete injury, and 262 veterans (64.8%) had an incomplete injury. Only 17 veterans (4.2%) had no drug interactions. The number of drug interactions varied from 1 to 38, with an average of 5.9 ± 12.8 interactions per patient. The total number of interactions was 2856, of which 32.5% were weak, 55.3% moderate, and 12.2% severe, with a 95% confidence interval. Among the severe drug interactions in the study, the highest number belonged to the antidepressant drugs.Conclusion: This study highlights the necessity of developing a strategy for investigating and preventing drug interactions in veterans with chronic spinal cord injury. It has recommended that physicians pay more attention to other medications used by the patient and prescribe as little as possible of the drug and the drug with the least number of interactions.","PeriodicalId":33222,"journal":{"name":"International Clinical Neuroscience Journal","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41514705","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Novel Coronavirus Characteristic Cerebrovasculopathic Effects 新型冠状病毒的特征性脑血管病变作用
Pub Date : 2020-09-28 DOI: 10.34172/ICNJ.2020.19
Sara Zandpazandi, M. Shahmohammadi
Stroke incidence of 0.9%-2% in especially young COVID-19 patients, is reported. The worst issue about this incidence is the high mortality rate despite even optimal treatment. Since the number of patients is as much as the World Health Organization (WHO) could declare the disease pandemic, it is important to review the pathophysiology in order to estimate the risk and guide the decision making. This letter aims to review the mechanism of virus pathophysiology and the following cerebrovascular presentations reported until now.
据报道,特别是年轻的新冠肺炎患者的中风发病率为0.9%-2%。这种发病率最糟糕的问题是,尽管进行了最佳治疗,但死亡率仍然很高。由于患者人数与世界卫生组织(世界卫生组织)可能宣布的疾病大流行人数一样多,因此重要的是审查病理生理学,以评估风险并指导决策。这封信旨在综述病毒的病理生理机制以及迄今为止报道的以下脑血管表现。
{"title":"Novel Coronavirus Characteristic Cerebrovasculopathic Effects","authors":"Sara Zandpazandi, M. Shahmohammadi","doi":"10.34172/ICNJ.2020.19","DOIUrl":"https://doi.org/10.34172/ICNJ.2020.19","url":null,"abstract":"Stroke incidence of 0.9%-2% in especially young COVID-19 patients, is reported. The worst issue about this incidence is the high mortality rate despite even optimal treatment. Since the number of patients is as much as the World Health Organization (WHO) could declare the disease pandemic, it is important to review the pathophysiology in order to estimate the risk and guide the decision making. This letter aims to review the mechanism of virus pathophysiology and the following cerebrovascular presentations reported until now.","PeriodicalId":33222,"journal":{"name":"International Clinical Neuroscience Journal","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44769342","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Investigating the Association Between Serum Vitamin D Deficiency and Idiopathic Benign Paroxysmal Positional Vertigo 血清维生素D缺乏与特发性良性发作性位置性眩晕的相关性研究
Pub Date : 2020-06-21 DOI: 10.34172/icnj.2020.12
Jignesh Dhirubhai Dhameliya, U. Chandra, S. Vishwakarma, Dattaprasad Ganganpalli, A. Verma
Background: It is suggested that there is a positive association between vitamin D deficiency and benign paroxysmal positional vertigo (BPPV). We suggest, as a hypothesis, there is a positive association between vitamin D deficiency and BPPV. The current study aimed to investigate the association between vitamin D levels and BPPV.Methods: The present observational case-control study was planned and conducted on 100 participants (50 cases and 50 controls) in the Department of Neurology, Choithram Hospital & Research Center (CHRC), Indore, MP, India, from January 2018 to December 2018. All consecutive patients with diagnosis of idiopathic BPPV who were above the age of 18 years with a negative neurological status were included. Analyses were performed using SPSS software version 10. Results: BPPV was more common among those aged 50 to 70 years (64%). Out of 100 participants, 72 (72%) had vitamin D deficiency, in which 40 (80%) were cases and 32 (64%) were controls. 32 (64%) patients had posterior canal involved, out of them 20 (40%) were females and 12 (24%) were males, and in both groups posterior canal was more involved. Canal involvement according to gender was not statistically significant (P value=0.45). Mean vitamin D level for cases and controls was 34.9 and 46.5 nmol/L, respectively, and this difference was statically very significant with a p-value of 0.01 (P value < 0.05).Conclusion: According to the findings, there is a statistically significant association between vitamin D3 deficiency and Idiopathic BPPV. It can be noted that vitamin D3 deficiency may be a risk factor for the BPPV.
背景:维生素D缺乏与良性阵发性位置性眩晕(BPPV)之间存在正相关。我们认为,作为一种假设,维生素D缺乏与BPPV之间存在正相关。本研究旨在调查维生素D水平与BPPV之间的关系。方法:本观察性病例对照研究计划于2018年1月至2018年12月在印度MP印多尔Choithram医院和研究中心(CHRC)神经内科对100名参与者(50例病例和50名对照)进行。所有连续诊断为特发性BPPV的患者,年龄在18岁以上,神经系统状况为阴性,均包括在内。使用SPSS软件版本10进行分析。结果:BPPV在50-70岁人群中更为常见(64%)。在100名参与者中,72人(72%)患有维生素D缺乏症,其中40人(80%)为病例,32人(64%)为对照组。32例(64%)患者有后管受累,其中20例(40%)为女性,12例(24%)为男性,两组患者后管受累较多。不同性别的椎管受累无统计学意义(P值=0.45)。病例和对照组的平均维生素D水平分别为34.9和46.5 nmol/L,这一差异在统计学上非常显著,P值为0.01(P值<0.05)。结论:根据研究结果,维生素D3缺乏与特发性BPPV之间存在统计学上显著的相关性。可以注意到,维生素D3缺乏可能是BPPV的一个危险因素。
{"title":"Investigating the Association Between Serum Vitamin D Deficiency and Idiopathic Benign Paroxysmal Positional Vertigo","authors":"Jignesh Dhirubhai Dhameliya, U. Chandra, S. Vishwakarma, Dattaprasad Ganganpalli, A. Verma","doi":"10.34172/icnj.2020.12","DOIUrl":"https://doi.org/10.34172/icnj.2020.12","url":null,"abstract":"Background: It is suggested that there is a positive association between vitamin D deficiency and benign paroxysmal positional vertigo (BPPV). We suggest, as a hypothesis, there is a positive association between vitamin D deficiency and BPPV. The current study aimed to investigate the association between vitamin D levels and BPPV.Methods: The present observational case-control study was planned and conducted on 100 participants (50 cases and 50 controls) in the Department of Neurology, Choithram Hospital & Research Center (CHRC), Indore, MP, India, from January 2018 to December 2018. All consecutive patients with diagnosis of idiopathic BPPV who were above the age of 18 years with a negative neurological status were included. Analyses were performed using SPSS software version 10. Results: BPPV was more common among those aged 50 to 70 years (64%). Out of 100 participants, 72 (72%) had vitamin D deficiency, in which 40 (80%) were cases and 32 (64%) were controls. 32 (64%) patients had posterior canal involved, out of them 20 (40%) were females and 12 (24%) were males, and in both groups posterior canal was more involved. Canal involvement according to gender was not statistically significant (P value=0.45). Mean vitamin D level for cases and controls was 34.9 and 46.5 nmol/L, respectively, and this difference was statically very significant with a p-value of 0.01 (P value < 0.05).Conclusion: According to the findings, there is a statistically significant association between vitamin D3 deficiency and Idiopathic BPPV. It can be noted that vitamin D3 deficiency may be a risk factor for the BPPV.","PeriodicalId":33222,"journal":{"name":"International Clinical Neuroscience Journal","volume":"7 1","pages":"122-126"},"PeriodicalIF":0.0,"publicationDate":"2020-06-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41992985","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Effectiveness of Extremely Low Frequency Electromagnetic Field and Pulsed Low Level Laser Therapy in Acute Stroke Treatment 极低频电磁场与脉冲低能级激光治疗急性脑卒中疗效观察
Pub Date : 2020-06-21 DOI: 10.34172/icnj.2020.13
F. Ashrafi, A. Rezaei, Arash Azhideh, F. Tabeie, L. Gachkar, M. Ahmadi, Maryam Yousefi-Asl, A. Zali, R. Khoshnoud
Introduction: Stroke is one of the most devastating neurologic conditions in the world. Despite all the efforts that have been made for effective treatment, the prevalence of this medical condition is still high. One of the new methods in the treatment of patients is the use of low power laser and pulsed magnetic fields. The previous studies investigated the effectiveness of these methods individually. However, the present study aimed to investigate their effectiveness in combination.Methods: We divided the patients into control (n = 26) and experimental (n=26) groups. The primary variables included the Mini-Mental State Examination (MMSE) and the National Institute of Health Stroke Scale (NIHSS). The experimental group received Extremely Low-Frequency Electromagnetic Field (EMF-ELF) treatment with 1 mT power and laser in rejection with a wavelength of 840 nm for 5 days and 45 minutes per day. Results: The variable measured during this study, in addition to comparing the results of the intervention between the control and experimental groups, showed a significant difference in all indicators before and after the intervention. The mean and standard deviations of the Modified Rankin Scale (mRS), functional status (Barthel’s index), and cognitive status (MMSE) (p<0.001) were signed between two groups.Conclusion: Laser and magnetic field combination can be effective in the treatment of stroke. Further studies are recommended to ensure a better comparison.Keywords:  Stroke; Low Level Light Therapy; Electromagnetic Field; Nonablative Laser Treatments
中风是世界上最具破坏性的神经系统疾病之一。尽管为有效治疗作出了各种努力,但这种疾病的发病率仍然很高。治疗病人的新方法之一是使用低功率激光和脉冲磁场。以前的研究分别调查了这些方法的有效性。然而,本研究旨在探讨它们联合使用的有效性。方法:将患者分为对照组(n=26)和实验组(n=26)。主要变量包括简易精神状态检查(MMSE)和美国国立卫生研究院卒中量表(NIHSS)。实验组采用极低频电磁场(EMF-ELF)治疗,功率为1mt,排斥激光波长为840nm,持续5天,每天45分钟。结果:本研究测量的变量,除了比较对照组与实验组的干预结果外,在干预前后各项指标均有显著差异。修正Rankin量表(mRS)、功能状态(Barthel指数)和认知状态(MMSE)的均数和标准差在两组间比较(p<0.001)。结论:激光与磁场联合治疗脑卒中疗效显著。建议进一步研究以确保更好的比较。关键词:中风;微光疗法;电磁场;非烧蚀激光治疗
{"title":"Effectiveness of Extremely Low Frequency Electromagnetic Field and Pulsed Low Level Laser Therapy in Acute Stroke Treatment","authors":"F. Ashrafi, A. Rezaei, Arash Azhideh, F. Tabeie, L. Gachkar, M. Ahmadi, Maryam Yousefi-Asl, A. Zali, R. Khoshnoud","doi":"10.34172/icnj.2020.13","DOIUrl":"https://doi.org/10.34172/icnj.2020.13","url":null,"abstract":"Introduction: Stroke is one of the most devastating neurologic conditions in the world. Despite all the efforts that have been made for effective treatment, the prevalence of this medical condition is still high. One of the new methods in the treatment of patients is the use of low power laser and pulsed magnetic fields. The previous studies investigated the effectiveness of these methods individually. However, the present study aimed to investigate their effectiveness in combination.Methods: We divided the patients into control (n = 26) and experimental (n=26) groups. The primary variables included the Mini-Mental State Examination (MMSE) and the National Institute of Health Stroke Scale (NIHSS). The experimental group received Extremely Low-Frequency Electromagnetic Field (EMF-ELF) treatment with 1 mT power and laser in rejection with a wavelength of 840 nm for 5 days and 45 minutes per day. Results: The variable measured during this study, in addition to comparing the results of the intervention between the control and experimental groups, showed a significant difference in all indicators before and after the intervention. The mean and standard deviations of the Modified Rankin Scale (mRS), functional status (Barthel’s index), and cognitive status (MMSE) (p<0.001) were signed between two groups.Conclusion: Laser and magnetic field combination can be effective in the treatment of stroke. Further studies are recommended to ensure a better comparison.Keywords:  Stroke; Low Level Light Therapy; Electromagnetic Field; Nonablative Laser Treatments","PeriodicalId":33222,"journal":{"name":"International Clinical Neuroscience Journal","volume":"7 1","pages":"127-131"},"PeriodicalIF":0.0,"publicationDate":"2020-06-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43792136","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Noninvasive Deep Brain Stimulation 无创脑深部刺激
Pub Date : 2020-06-21 DOI: 10.34172/icnj.2020.10
P. Azimi, A. Zali
{"title":"Noninvasive Deep Brain Stimulation","authors":"P. Azimi, A. Zali","doi":"10.34172/icnj.2020.10","DOIUrl":"https://doi.org/10.34172/icnj.2020.10","url":null,"abstract":"<jats:p>\u0000 </jats:p>","PeriodicalId":33222,"journal":{"name":"International Clinical Neuroscience Journal","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-06-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48627099","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
The Anxiety Disorder Among the Healthcare Providers During The COVID-19 Infection Pandemic: A Systematic Review 新冠肺炎感染大流行期间医疗服务提供者的焦虑症:系统综述
Pub Date : 2020-06-21 DOI: 10.34172/icnj.2020.11
Sepideh Paybast, Fatemeh Baghalha, A. Emami, Mohsen Koosha
Background: The outbreak of the novel coronavirus disease (COVID-19) imposes a considerable psychological burden on the medical staff working in central hospitals for COVID-19. In this systematic review, we will discuss the prevalence and the risk factors of anxiety disorder among the frontline medical staff dealing with COVID-19 patients.Methods: PubMed, Scopus, Embase, Web of Science data bases were systematically searched from December 01, 2019 to April 30, 2020 for related published articles. In all electronic databases, the following search strategy was implemented and these key words (in the title/abstract) were used: “COVID-19” OR “novel Coronavirus” AND “anxiety” OR “psychology” OR “psychiatry” OR “psychological distress” AND “nurses” or “clinicians”. We included only the cross sectional studies.Results: Through the search strategy, we could identify eight related cross sectional articles about anxiety among the healthcare workers in central hospitals for COVID-19 infection. However, the authors scanned the reference lists of the included studies and identified multiple references. According to our findings, the frontline medical staff are at risk developing anxiety disorder which is mainly mild. Additionally, the female nurses are more susceptible to experience anxiety during the COVID-19 pandemic.Conclusion: Regarding to the outbreak of COVID-19 worldwide and the workload of the frontline medical staff dealing with COVID-19 patients, a particular attention should be given on the mental health of the healthcare provides.
背景:新型冠状病毒病(新冠肺炎)的爆发给新冠肺炎中心医院的医护人员带来了巨大的心理负担。在这篇系统综述中,我们将讨论新冠肺炎患者的一线医务人员中焦虑症的患病率和危险因素。方法:从2019年12月1日至2020年4月30日,系统检索PubMed、Scopus、Embase、Web of Science数据库中的相关发表文章。在所有电子数据库中,实施了以下搜索策略,并使用了这些关键词(标题/摘要):“新冠肺炎”或“新型冠状病毒”与“焦虑”或“心理学”或“精神病学”或“心理困扰”与“护士”或“临床医生”。我们只包括横断面研究。结果:通过搜索策略,我们可以识别出8篇关于新冠肺炎感染中心医院医护人员焦虑的相关横断面文章。然而,作者扫描了纳入研究的参考文献列表,并确定了多个参考文献。根据我们的研究结果,一线医务人员有患焦虑症的风险,焦虑症主要是轻度的。此外,在新冠肺炎大流行期间,女护士更容易感到焦虑。结论:鉴于新冠肺炎疫情在全球范围内的爆发以及一线医护人员处理新冠肺炎患者的工作量,应特别关注医护人员的心理健康。
{"title":"The Anxiety Disorder Among the Healthcare Providers During The COVID-19 Infection Pandemic: A Systematic Review","authors":"Sepideh Paybast, Fatemeh Baghalha, A. Emami, Mohsen Koosha","doi":"10.34172/icnj.2020.11","DOIUrl":"https://doi.org/10.34172/icnj.2020.11","url":null,"abstract":"Background: The outbreak of the novel coronavirus disease (COVID-19) imposes a considerable psychological burden on the medical staff working in central hospitals for COVID-19. In this systematic review, we will discuss the prevalence and the risk factors of anxiety disorder among the frontline medical staff dealing with COVID-19 patients.Methods: PubMed, Scopus, Embase, Web of Science data bases were systematically searched from December 01, 2019 to April 30, 2020 for related published articles. In all electronic databases, the following search strategy was implemented and these key words (in the title/abstract) were used: “COVID-19” OR “novel Coronavirus” AND “anxiety” OR “psychology” OR “psychiatry” OR “psychological distress” AND “nurses” or “clinicians”. We included only the cross sectional studies.Results: Through the search strategy, we could identify eight related cross sectional articles about anxiety among the healthcare workers in central hospitals for COVID-19 infection. However, the authors scanned the reference lists of the included studies and identified multiple references. According to our findings, the frontline medical staff are at risk developing anxiety disorder which is mainly mild. Additionally, the female nurses are more susceptible to experience anxiety during the COVID-19 pandemic.Conclusion: Regarding to the outbreak of COVID-19 worldwide and the workload of the frontline medical staff dealing with COVID-19 patients, a particular attention should be given on the mental health of the healthcare provides.","PeriodicalId":33222,"journal":{"name":"International Clinical Neuroscience Journal","volume":"7 1","pages":"115-121"},"PeriodicalIF":0.0,"publicationDate":"2020-06-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48934635","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 10
Guillain-Barre syndrome as a neurological complication of COVID-19 infection: a case series and review of the literature 格林-巴利综合征作为新冠肺炎感染的神经并发症:病例系列和文献回顾
Pub Date : 2020-06-21 DOI: 10.34172/icnj.2020.18
H. Mozhdehipanah, Sepideh Paybast, R. Gorji
Background: The novel coronavirus (COVID-19) is a global pandemic. Although the main clinical manifestations of the COVID-19 infection has confined to the respiratory system, there is some evidence suggesting the neuro-invasive potential of the COVID-19. There are limited reports of Guillain–Barre syndrome (GBS) as a peripheral nervous system complication of COVID-19 infection.Methods and results: We described four patients with COVID-19 infection who developed acute polyneuropathy with a final diagnosis of Guillain–Barre syndrome.Conclusion: COVID-19 may have the potential to invade the peripheral nervous system. GBS, as one of the critical neurological complications of COVID-19, could be considered as a post-infectious event.
背景:新型冠状病毒(新冠肺炎)是一种全球性流行病。尽管新冠肺炎感染的主要临床表现仅限于呼吸系统,但有证据表明新冠肺炎具有神经侵袭潜力。格林-巴利综合征(GBS)作为新冠肺炎感染的外周神经系统并发症的报道有限。方法和结果:我们描述了四名新冠肺炎感染患者,他们发展为急性多发性神经病,最终诊断为格林-巴利综合征。结论:新冠肺炎可能具有侵袭周围神经系统的潜力。GBS作为新冠肺炎的重要神经并发症之一,可被视为感染后事件。
{"title":"Guillain-Barre syndrome as a neurological complication of COVID-19 infection: a case series and review of the literature","authors":"H. Mozhdehipanah, Sepideh Paybast, R. Gorji","doi":"10.34172/icnj.2020.18","DOIUrl":"https://doi.org/10.34172/icnj.2020.18","url":null,"abstract":"Background: The novel coronavirus (COVID-19) is a global pandemic. Although the main clinical manifestations of the COVID-19 infection has confined to the respiratory system, there is some evidence suggesting the neuro-invasive potential of the COVID-19. There are limited reports of Guillain–Barre syndrome (GBS) as a peripheral nervous system complication of COVID-19 infection.Methods and results: We described four patients with COVID-19 infection who developed acute polyneuropathy with a final diagnosis of Guillain–Barre syndrome.Conclusion: COVID-19 may have the potential to invade the peripheral nervous system. GBS, as one of the critical neurological complications of COVID-19, could be considered as a post-infectious event.","PeriodicalId":33222,"journal":{"name":"International Clinical Neuroscience Journal","volume":"7 1","pages":"156-161"},"PeriodicalIF":0.0,"publicationDate":"2020-06-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45338657","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 19
Expression of the Apoptotic Proteins in Glioblastoma U87-MG Cell Line Treated by Botulinum Toxin 肉毒杆菌毒素作用下胶质母细胞瘤U87-MG细胞凋亡蛋白的表达
Pub Date : 2020-06-21 DOI: 10.34172/icnj.2020.14
M. Farhadi, S. Moniri, M. Jameie, Nasrin Hosseini, M. Jameie, S. B. Jameie
Background: Glioblastoma multiforme (GBM) is the most type of brain malignancy in adults. Radical excision surgery, chemotherapy, and radiotherapy in some cases are still unsuccessful, and most patients with GBM die within three to six months following diagnosis. Botulinum toxin type A (BtxA) has cellular toxin effects and suppresses the cell division of certain types of cancer cell lines in vivo and in vitro study. The present study designed to evaluate the apoptotic effect of BtxA on the GBM cell line.Material & methods: U87-MG GBM cell line cultured according to the routing protocols, divided into two groups including, trial (BtxA treated) and control groups. Cells of the trial group exposed to different doses of BtxA. The cell viability, cycle arrest, and pro-apoptotic proteins evaluated respectively by MTT assay, SubG1, and Western blotting.Results: MTT assay showed that the viability of the BtxA treated cells at doses of 1.45 Unit and other doses after 24 to 48 hours, significantly decreased (p<0.001) compared to the control groups. Apoptosis percentage of the SubG1 test also indicated that 1.45 Unit dose significantly increased in the cells exposed to BtxA compared to the control group in 24 hours. The expression of P53 and Caspase 3 proteins indicated a significant increase.Conclusion: BtxA induces apoptosis in U87- MG cell line via p53 and caspase three pathways and could have clinical applications. In vivo studies need to confirm the clinical application of the present findings.
背景:多形性胶质母细胞瘤(GBM)是成人最常见的脑恶性肿瘤。在某些情况下,根治性切除手术、化疗和放疗仍然不成功,大多数GBM患者在确诊后三到六个月内死亡。A型肉毒毒素(BtxA)具有细胞毒素效应,在体内外研究中抑制某些类型癌症细胞系的细胞分裂。本研究旨在评价BtxA对GBM细胞系的凋亡作用。材料与方法:U87-MG GBM细胞系按培养方案培养,分为试验组(BtxA处理)和对照组。试验组的细胞暴露于不同剂量的BtxA。细胞活力、周期阻滞和促凋亡蛋白分别通过MTT法、SubG1法和Western印迹法进行评估。结果:MTT分析显示,与对照组相比,1.45单位剂量和其他剂量的BtxA处理的细胞在24-48小时后的生存能力显著降低(p<0.001)。SubG1试验的细胞凋亡百分比还表明,与对照组相比,暴露于BtxA的细胞在24小时内1.45单位剂量显著增加。P53和Caspase 3蛋白表达显著增加。结论:BtxA通过p53和caspase三种途径诱导U87-MG细胞凋亡,具有临床应用价值。体内研究需要证实目前研究结果的临床应用。
{"title":"Expression of the Apoptotic Proteins in Glioblastoma U87-MG Cell Line Treated by Botulinum Toxin","authors":"M. Farhadi, S. Moniri, M. Jameie, Nasrin Hosseini, M. Jameie, S. B. Jameie","doi":"10.34172/icnj.2020.14","DOIUrl":"https://doi.org/10.34172/icnj.2020.14","url":null,"abstract":"Background: Glioblastoma multiforme (GBM) is the most type of brain malignancy in adults. Radical excision surgery, chemotherapy, and radiotherapy in some cases are still unsuccessful, and most patients with GBM die within three to six months following diagnosis. Botulinum toxin type A (BtxA) has cellular toxin effects and suppresses the cell division of certain types of cancer cell lines in vivo and in vitro study. The present study designed to evaluate the apoptotic effect of BtxA on the GBM cell line.Material & methods: U87-MG GBM cell line cultured according to the routing protocols, divided into two groups including, trial (BtxA treated) and control groups. Cells of the trial group exposed to different doses of BtxA. The cell viability, cycle arrest, and pro-apoptotic proteins evaluated respectively by MTT assay, SubG1, and Western blotting.Results: MTT assay showed that the viability of the BtxA treated cells at doses of 1.45 Unit and other doses after 24 to 48 hours, significantly decreased (p<0.001) compared to the control groups. Apoptosis percentage of the SubG1 test also indicated that 1.45 Unit dose significantly increased in the cells exposed to BtxA compared to the control group in 24 hours. The expression of P53 and Caspase 3 proteins indicated a significant increase.Conclusion: BtxA induces apoptosis in U87- MG cell line via p53 and caspase three pathways and could have clinical applications. In vivo studies need to confirm the clinical application of the present findings.","PeriodicalId":33222,"journal":{"name":"International Clinical Neuroscience Journal","volume":"7 1","pages":"132-137"},"PeriodicalIF":0.0,"publicationDate":"2020-06-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48551067","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
International Clinical Neuroscience Journal
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1